NFKB1 and B-cell chronic lymphocytic leukemia: In CLL and several BCL, aberrant NF-κB activation is the result of genetic alterations in pathways leading to NF-κB activation and aberrant stimulation from the microenvironment (through BCR, CD40, and TLR)2,3,5,6,8,10–12,32.